Physicochemical Properties of Natural Based Products versus Synthetic Chemicals

The majority of the currently used cosmetics and drugs are natural products-based compounds or their deriva- tives. This could add weight to the argument that natural based products are inherently better tolerated in the body than synthetic chemicals and have higher chance to be approved as new drugs. The present study was undertaken to analyze a natural product database compared to synthetic chemicals and to search for discriminative physicochemical properties that may probably help in differentiating between natural and synthetic compounds. We have formulated rules to assess the natural likeness of chemicals and thereby discriminate between natural-based and synthetic chemicals. A Mathews Corre- lation Coefficient of 0.5 was obtained; nearly 81% of natural-based products and 68% of synthetic chemicals were pre- cisely classified using this filter. The property criteria for drug-likeness and lead-likeness are more pronounced in natural products rather than synthetic ones. The fraction of synthetic chemicals which are natural-like could have higher chance to be successful drug.

[1]  A. Schuffenhauer,et al.  Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Langer,et al.  Strategies for efficient lead structure discovery from natural products. , 2006, Current medicinal chemistry.

[3]  Peter Ertl,et al.  Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries , 2008, J. Chem. Inf. Model..

[4]  D. Soejarto,et al.  Biodiversity as a source of anticancer drugs. , 2006, Current drug targets.

[5]  W. Setzer,et al.  Comparative Molecular Docking of Antitrypanosomal Natural Products into Multiple Trypanosoma brucei Drug Targets , 2009, Molecules.

[6]  Simone Brogi,et al.  Pharmacophore Modeling for Qualitative Prediction of Antiestrogenic Activity , 2009, J. Chem. Inf. Model..

[7]  G. Rishton,et al.  Natural products as a robust source of new drugs and drug leads: past successes and present day issues. , 2008, The American journal of cardiology.

[8]  Amiram Goldblum,et al.  Predicting Oral Druglikeness by Iterative Stochastic Elimination , 2010, J. Chem. Inf. Model..

[9]  M Paul Gleeson,et al.  Assessing the drug-likeness of lamellarins, a marine-derived natural product class with diverse oncological activities. , 2010, European journal of medicinal chemistry.

[10]  Herbert Waldmann,et al.  From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries. , 2002, Angewandte Chemie.

[11]  D. Newman,et al.  Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.

[12]  Ian Paterson,et al.  The Renaissance of Natural Products as Drug Candidates , 2005, Science.

[13]  Wei Lu,et al.  Do Biologically Relevant Compounds Have More Chance To Be Drugs? , 2009, J. Chem. Inf. Model..

[14]  Thierry Langer,et al.  Virtual screening for the discovery of bioactive natural products , 2008, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[15]  M. Desai,et al.  Rediscovering the role of natural products in drug discovery. , 2008, Current opinion in drug discovery & development.

[16]  William L Jorgensen,et al.  Efficient drug lead discovery and optimization. , 2009, Accounts of chemical research.

[17]  Yang Li,et al.  Structure-based discovery of potassium channel blockers from natural products: virtual screening and electrophysiological assay testing. , 2003, Chemistry & biology.

[18]  Kaixian Chen,et al.  Virtual screening on natural products for discovering active compounds and target information. , 2003, Current medicinal chemistry.

[19]  Herbert Waldmann,et al.  Design of compound libraries based on natural product scaffolds and protein structure similarity clustering (PSSC). , 2005, Molecular bioSystems.

[20]  Tudor I. Oprea,et al.  Toward minimalistic modeling of oral drug absorption. , 1999, Journal of molecular graphics & modelling.

[21]  J. Vederas,et al.  Drug Discovery and Natural Products: End of an Era or an Endless Frontier? , 2009, Science.

[22]  G. Schneider,et al.  Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. , 2001, Journal of combinatorial chemistry.

[23]  A. Rayan,et al.  Stochastic algorithm for kinase homology model construction. , 2004, Current medicinal chemistry.

[24]  N. Romeiro,et al.  Structural insights into IKKbeta inhibition by natural products staurosporine and quercetin. , 2009, Bioorganic & medicinal chemistry letters.

[25]  Yi Wang,et al.  A causal relationship discovery-based approach to identifying active components of herbal medicine , 2006, Comput. Biol. Chem..

[26]  Bethan Hughes,et al.  2007 FDA drug approvals: a year of flux , 2008, Nature Reviews Drug Discovery.

[27]  Iwao Ojima,et al.  Modern natural products chemistry and drug discovery. , 2008, Journal of medicinal chemistry.

[28]  David J Newman,et al.  Marine natural products and related compounds in clinical and advanced preclinical trials. , 2004, Journal of natural products.

[29]  T Langer,et al.  Integrated in silico tools for exploiting the natural products' bioactivity. , 2006, Planta medica.

[30]  Bethan Hughes,et al.  2008 FDA drug approvals , 2009, Nature Reviews Drug Discovery.

[31]  Alan Harvey.  The Role of Natural Products in Drug Discovery , 2000, Ernst Schering Research Foundation Workshop.

[32]  J. Beutler,et al.  Natural Products as a Foundation for Drug Discovery , 2009, Current protocols in pharmacology.

[33]  Robert Bywater,et al.  Improving the Odds in Discriminating "Drug-like" from "Non Drug-like" Compounds , 2000, J. Chem. Inf. Comput. Sci..

[34]  Jürgen Bajorath,et al.  Distinguishing between Natural Products and Synthetic Molecules by Descriptor Shannon Entropy Analysis and Binary QSAR Calculations , 2000, J. Chem. Inf. Comput. Sci..

[35]  Gisbert Schneider,et al.  Structure‐Based Pharmacophore Screening for Natural‐Product‐Derived PPARγ Agonists , 2009, Chembiochem : a European journal of chemical biology.

[36]  K. Lee.  Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach. , 2010, Journal of natural products.

[37]  Alan L Harvey,et al.  Natural products in drug discovery. , 2008, Drug discovery today.

[38]  G. Schneider,et al.  Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. , 2007, Journal of medicinal chemistry.

[39]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[40]  J. Mcchesney,et al.  Plant natural products: back to the future or into extinction? , 2007, Phytochemistry.

[41]  R. Vijayakrishnan.  Structure-based drug design and modern medicine. , 2009, Journal of postgraduate medicine.

[42]  Theodora M. Steindl,et al.  Structure-based virtual screening for the discovery of natural inhibitors for human rhinovirus coat protein. , 2008, Journal of medicinal chemistry.